Global Health 2020Over the next five years, we expect to see a surge of innovation emerging from

the research and development pipeline, as well as a range of technology-enabled

transformations that will expand the evidence-basis for interventions and bring

measurable improvements to health outcomes by 2020.

Learn more: http://www.imshealth.com/en/thought-leadership/ims-institute

A look to 2020The volume of medicines used globally will reach 4.5 trillion doses and spending will reach $1.4 trillion.

More than 50% of the world’s population will live in countries where average medicine consumption is more than 1 dose per person per day, up from 33% of the world in 2005.

• China, India, Brazil and Indonesia, with a combined population of 3.23 billion in 2020, will account for nearly half of the increased volume in medicine usage globally.

Global spending on medicines in 202028% of global spending will be for specialty medicines, especially in developed markets, with more than $100 billion dedicated to oncology.

The key drivers of the spending growth over the next five years:

• access expansion in pharmerging countries

• greater use of more expensive branded medicines in developed markets

• increased availability of cheaper alternatives when loss of exclusivity occurs

Innovation will drive transformation of disease treatments225 new active substances will be launched over the next five years, bringing the total number since 1996 to more than 940.

Over 470 drugs will be available to treat orphan diseases for the 7,000 rare diseases with no or limited treatments available.

Change is happening.